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Traditional knowledgeAbstract Antiviral activity against H1N1 inﬂuenza was studied using ethnic medicinal plants of
South India. Results revealed that Wrightia tinctoria (2.25 lg/ml) was one of the best antidotes
against H1N1 virus in terms of inhibitory concentration of 50% (IC50) whereas the control drug
Oseltamivir showed 6.44 lg/ml. Strychnos minor, Diotacanthus albiﬂorus and Cayratia pedata
showed low cytotoxicity (>100) to the MDCK (Malin darby canine kidney) cells by cytotoxicity
concentration of 50% (CC50) and possessed antiviral activity suggesting that these plants can be
used as herbal capsules for H1N1 virus. W. tinctoria and S. minor showed high therapeutic indexes
(TI) such as 12.67 and 21.97 suggesting that those plants can be used for anti-viral drug develop-
ment. The CC50 values of Eugenia singampattiana (0.3 lg/ml), Vitex altissima (42 lg/ml), Salacia
oblonga (7.32 lg/ml) and Salacia reticulata (7.36 lg/ml) resulted in cytotoxicity of the MDCK cells,
due to their high phenolic content. Findings from this study state that the plantW. tinctoria can be
a potent source for third generation anti-viral drug development against H1N1.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Viruses are one of the major infective agents causing various
health problems to humans resulting in death every year
(Rajasekaran et al., 2013). Among the viral diseases inﬂuenza
plays a vital role in humans and animals causing serious illness
and major ﬁnancial strain/stress. H1N1 viruses are more con-
tagious and were reported to have caused serious problems in
many countries. In Canada, the inﬂuenza virus was identiﬁed
in 1 of 1.6 admissions during 2010 inﬂuenza season
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various subtypes like A and B and these two types of H1N1
virus were predominantly found among the human population
affecting their day-to-day life. Generally these viruses cause
acute respiratory infections referred to as ‘‘ﬂu’’ resulting in
serious problems particularly to children. Even though vac-
cines are available for ﬂu, it was reported that only 50% were
effective among the elderly persons (Wang et al., 2006). More-
over this virus subtypes A and B spread globally and its muta-
tions that create antigenic drift and shift have been reported
(Stein et al., 2009). This necessitated a serious search for better
antiviral drugs.
Medicinal plants are termed to be one of the easy sources to
get antiviral drugs since they have a proven record for antiviral
activity. Tribals living worldwide traditionally have been using
most of the medicinal plants successfully for many decades
(Gurib-Fakim, 2006). Transmitting the medicinal plant formu-
lae for curing some lethal diseases orally from generation to
generation resulting in the loss of various valuable medicinal
plant information (Nadembega et al., 2011). Even today a
majority of the developing country’s population depends on
herbal medicines for their primary health care (Goleniowski
et al., 2006). Due to this reason studies on medicinal plants
to ﬁnd new anti-viral drug developments for various diseases
were required, since 40% of all chemical drugs were derived
from the plant source. India is where Siddha and Ayurveda
medicines are common and the Traditional healers, spread
all over the country have immense knowledge in curing many
human diseases by using medicinal plants (Muthu et al., 2006).
Medicinal plants with a potential to cure can be taken up for
scientiﬁc studies to see if it can combat viral diseases, with
the hope of ﬁnding next generation drugs for inﬂuenza.
Coscinium fenestratum, Trichopus zeylanicus, Eugenia sing-
ampattiana, Vitex altissima, Strychnos minor, Diotacanthus
albiﬂorus, Strychnos nux-vomica, Chloroxylon swietenia, Helic-
teres isora, Andrographis paniculata, Wrightia tinctoria, Cayra-
tia pedata, Salacia oblonga and Salacia reticulata are some of
the medicinal plants commonly used by natives and tribals
of Tamil Nadu, South India. Among them S. minor and E.
singampattiana were used by Kani tribes of South India for
snake bites (Ayyanar, 2008), asthma and as anti-tumour
agent(Viswanathan et al., 2006; Kala et al., 2011). Coscinium
sps., and Salacia sps. were reported for their anti-diabetic
and anti-inﬂammatory activities (Nayak et al., 2013;
Ravishankar et al., 2013; Yoshino et al., 2009; Ismail et al.,
1997). Chloroxylon sps., Cayratia sps. and Trichopus sps. were
reported for their antioxidant activity and metabolic content
by Nilip and Gouri, (2013), Perumal et al., (2012), Tharakan
et al., (2005). Duraipandiyan et al., (2006), Ponnusamy et al.
(2011) studied the antimicrobial properties of Diotacanthus
sps. and Wrightia sps.
A. paniculata was reported for use against ﬂu and possesses
antiviral activity (Arora et al., 2010; Coon and Ernst, 2004).
Apart from A. paniculata all other plants were reported for
antioxidant properties and not against antiviral properties.
Since these plants are highly used as medicine by the natives
their activity against H1N1 inﬂuenza virus will provide alter-
native therapeutic formulation and be helpful for the human
kind. Previous studies of herbal made medicines like Shahaku-
san, hochuekkito, Jinchai and Lianhuaqingwen capsules are
proven for its effectiveness against virus by blocking transcrip-
tion and replication resulting in the reduction of the illnessperiod (Dan et al., 2013; Hokari et al., 2012; Zhong et al.,
2013; Duan et al., 2011).
Based on this background, a screening of selected south
Indian medicinal plants which are mostly used by ethnic and
native people are tested against H1N1 inﬂuenza virus. This
study will be helpful for new therapeutic agent (third genera-
tion inﬂuenza therapeutic compounds) preparation from the
medicinal plant which can be helpful for the humans to over-
come inﬂuenza since the virus was reported for its high muta-
tion ability against drugs.
2. Materials and methods
2.1. Chemicals
All the solvents used for the study were HPLC grade and the
chemicals were purchased from Sigma Aldrich (St. Louis,
MO, USA).
2.2. Plant materials
C. fenestratum (MP1), T. zeylanicus (MP2), E. singampattiana
(MP3), V. altissima (MP4), S. minor (MP5), D. albiﬂorus
(MP6), S. nux-vomica (MP7), C. swietenia (MP8), H. isora
(MP9), A. paniculata (MP10), W. tinctoria (MP11), C. pedata
(MP12, rhizome), C. pedata (MP13, collected from Kanyaku-
mari Dt, Tamil Nadu, India), C. pedata (MP14, collected from
Kanchipuram Dt, Tamil Nadu, India), S. oblonga (MP15) and
S. reticulata (MP16) plants were separately collected from
tropical and western Ghats region of South India. All the col-
lected plants were identiﬁed and conﬁrmed by an ethno-bota-
nist from Pachaiyappa’s college, Chennai, Tamil Nadu, India.
The leaves were shade dried before grinding and served as
plant source for the extraction.
2.3. Extraction of medicinal plants
All the plant samples (6 replicates) were taken separately and
weighed (0.1 g) in an Eppendorf tube (2 ml). 1 ml of 80%
methanol was added to the samples and vortexed, followed
by sonication for a period of 10 min. After that the methanol
was collected separately by centrifugation at 8000 rpm. This
step was continued twice and all the collected supernatants
were added together and evaporated to dryness using speed
vac. The resulting residues were redissolved in DMSO and
used for cell line studies. In the mean time for the total pheno-
lic and ﬂavonoid analysis, these extracts were dissolved using
100% methanol.
2.4. Cell culture
Madin Darby canine kidney (MDCK) cell and inﬂuenza AP/
R/8 virus (H1N1) were used for the present study. Inﬂuenza
AP/R/8 virus and MDCK cells were purchased from American
Type Culture Collection (ATCC). MDCK cell was maintained
at 32 C with 5% of CO2 in a relative humidiﬁed cell culture
incubator. Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
supplemented with 10% of fetal Bovine Serum (FBS) and
1% of Antibiotic–Antimycotic solution (100·) was used for
MDCK cell growth. DMEM, trypsin–EDTA, Antibiotic–
Antimycotic Solution 100x and FBS were purchased from
Figure 1 Free radical scavenging potential of selected medicinal
plants of South India. MP-medicinal plants. (A) DPPH radical
scavenging activity and (B) ABTS radical scavenging activity.
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Daegu, 704–948 Republic of Korea).
2.5. Antiviral assay
MDCK cells were seeded onto 96 well plates concentrated as
2 · 104 cells per well plate. After the ﬁrst day of growth, cells
seeded on the 96 well plates were washed twice with phosphate
buffer saline (PBS). Then Inﬂuenza AP/R/8 virus was diluted
as 5 · 103 with DMEM medium contained trypsin–EDTA
and this solution was used for the infection. Then, 90 lL of
virus solution and 10 lL of medicinal plant extracts were
placed onto the 96 well plates in which MDCK cells were
grown the previous day. Four different concentrations of the
extracts (0.1, 1, 10 and 100 lL) with three replicates of individ-
ual plant extracts were used in 96 well plates for the analysis.
Infected plates were incubated in CO2 incubator for a period
of 48 h. After incubation the medium was removed and
washed twice with PBS. After washing the plate, the cells were
ﬁxed by adding 70% of acetone followed by incubation at
4 C for a period of 1 h. Then the acetone was removed
and the plates were dried at 60 C under hot air oven. The
completely dried plates were incubated overnight with
100 lL of SRB (0.4 mg/L). After the overnight incubation,
SRB solution was removed and washed 3 times with 1% of
acetic acid and dried again under hot air oven at 60 C. Mor-
phology of the cells was observed under microscope (reﬂected
light microscope) under 40· magniﬁcation and images were
compared for their antiviral activity. After the microscopic
observation, the SRB strain was dissolved with 10 mM of Tris
base and incubated overnight. Based on the spectrophotomet-
ric data measured at 510 nm 50% of inhibition concentration
(IC50), cytotoxic concentration (CC50) and therapeutic index
(TI) value were obtained and calculated.
2.6. Total ﬂavonoid content (TFC) and total polyphenol content
(TPC)
The TFC was analysed by adding 20 lL of methanol extract
on 96-well plates and added with 180 lL of 90% diethylene
glycol and 20 lL of 1 N NaOH. The absorbance was measured
at 515 nm using a micro plate reader (Spectra max plus384,
Molecular devises, USA) after 15 min of incubation (Maria
John et al., 2014b).
For phenolic compound analysis, 20 lL of methanol
extracts was mixed with 100 lL of 0.2 N Folin–Ciocalteu’s
phenol reagent and 80 lL of saturated sodium carbonate.
After 1 h of incubation the samples were measured using a
microplate reader 750 nm (Maria John et al., 2014b).
2.7. Radical scavenging activity
The DPPH radical scavenging potentiality of the medicinal
plants was measured using 20 lL of methanol extract mixed
with 180 lL of DPPH (0.5 mM) reagent and was incubated
for 20 min. The absorbance was measured at 515 nm using a
micro plate reader (Maria John et al., 2014b).
In case of ABTS radical scavenging activity, 20 lL of meth-
anol extracts of all the medicinal plants was mixed with 180 lL
of ABTS solution and the absorbance was measured at 750 nm
using a micro-plate reader (Maria John et al., 2014c).2.8. Metabolite analysis by HPLC
Medicinal plant extracts were ﬁnally dissolved in MeOH and
was analysed under HPLC (Agilent 1100, USA) with water
and acetonitrile containing 0.1% formic acid served as mobile
phase A and B. The gradient ﬂow starts from 10% B and
reaches 90% at 30 min and 100% at 35 min followed by
10% at 40 min. The metabolic detection was made by using
authentic standard retention time (tR) and the detector
(DAD) was set at 254 nm.
2.9. Data analysis
The identiﬁed peak area was converted into log10 value and
was analysed using Statistica 7 software. Based on the box-
whisker plot the metabolites were compared between the sam-
ples. All data were statistically analysed using SPSS software
and were compared using excel graphs.
3. Results and discussion
3.1. Free radical scavenging potential of the selected medicinal
plants
DPPH and ABTS activities of the selected medicinal plants are
analysed and presented in Fig 1. The plants possess variation
in radical scavenging activity even between the two different
radical scavenging activities to the same plant extract. Com-
paring the plant extracts, MP2 followed by MP3 and MP7 pos-
sesses high DPPH radical scavenging activity; whereas MP13
and 14 followed by MP12 and 9 possess lowest scavenging
194 K.M. Maria John et al.activity (Fig. 1A). In the case of ABTS, MP15, MP16, MP9,
MP3 and MP4 possess high scavenging potential whereas
MP7, MP8, MP13 and MP6 showed lowest activity
(Fig. 1B). When comparing the two free radicals, the plant
MP7 showed high DPPH activity but its ABTS scavenging
potential was poor. MP9 showed high ABTS scavenging
potential but its DPPH scavenging potential was found to be
low than other medicinal plants analysed. MP8, MP12 and
MP2 were reported for high antioxidant activity (Nilip and
Gouri, 2013; Perumal et al., 2012; Tharakan et al., 2005). Anti-
oxidant and antiproliferative properties on human hepatoma
cells of Vitex sps. were reported by Kadir et al., (2013).
3.2. Effect of medicinal plant extracts against H1N1
The anti-viral activity of the medicinal plants at four different
concentrations along with standard drug (Oseltamivir) isFigure 2 Anti-viral activity of selected medicinal plants of South Ind
ml; Control drug-Oseltamivir.presented in Fig. 2. Result revealed that the plant possesses
variations in their anti viral activity against H1N1. Some of
the plants showed extremely higher activity against the virus
and some of the plants showed cytotoxic activity to the cells.
Based on the variations of IC50 and CC50 values the results
were compared. Crude extract of MP11 showed amazing activ-
ity against inﬂuenza H1N1 virus where the IC50 was 2.25 lg/
ml, CC50 was 28.6 lg/ml and TI was 12.7. In the control drug
‘oseltamivir’ it was seen that 6.44 lg/ml (IC50), >100 lg/ml
(CC50) and 15.5 (TI) values were observed. MP7 (33.4 lg/
ml), MP14 (37.3 lg/ml), MP5 (46.7 lg/ml), MP6 (60.1 lg/ml)
and MP13 (66 lg/ml) also showed good results against
H1N1 in terms of IC50 and CC50 values (MP7–20 lg/ml,
MP14- >100 lg/ml, MP5- 1026 lg/ml, MP6->100 lg/ml
and MP13- >100 lg/ml, respectively). When comparing the
extracts’ CC50 values it was observed that some of the medic-
inal plants such as MP3 (0.33 lg/ml), MP15 (7.32 lg/ml),ia against H1N1 by SRB assay. MP-medicinal plants; 0.1–100 lg/
Table 1 Concentrations of the medicinal plant extracts used
in the anti-viral assay and their toxicity against H1N1 virus.
Plant IC50 CC50 TI
MP1 32.42 + 3.94 42.33 1.31
MP2 72.41 + 9.91 70.00 0.97
MP3 81.97 + 13.2 0.33 0.004
MP4 1145.86 + 78 42.41 0.037
MP5 46.69 + 13.7 1026.08 21.97
MP6 60.09 + 4.2 >100 >1.66
MP7 33.36 + 1.07 20.00 0.60
MP8 – 50 –
MP9 216.93 + 50.63 >100 >0.46
MP10 – 26.63 –
MP11 2.25 + 0.22 28.55 12.67
MP12 142.85 + 30.8 55.21 0.38
MP13 65.99 + 2.65 >100 >1.52
MP14 37.29 + 7.2 >100 >2.68
MP15 60.87 + 7.22 7.32 0.12
MP16 25.09 + 3.83 7.36 0.29
Control drug 6.44 + 0.32 >100 >15.51
Control drug- Oseltamivir; IC50- Inhibitory concentration of 50%;
CC50- cytotoxicity concentration of 50%; TI- therapeutic index.
Figure 3 Total ﬂavonoid and polyphenol content of the selected
medicinal plants of South India. (A) Total ﬂavonoid content and
(B) Total polyphenol content.
South Indian ethnic medicinal plants against H1N1 195MP16 (7.37 lg/ml) and MP10 (26.6 lg/ml) had high cytotoxic-
ity to the MDCK cells (Fig. 2, Table 1). In our previous study
using MP3 extract showed anti viral activity against porcine
reproductive and respiratory syndrome viruses (Maria John
et al., 2014a). The plant MP10 was reported for its activity
against ﬂu by Coon and Ernst, (2004). But its cytotoxicity lev-
els and its impact on normal cells are not properly reported.
3.3. Total phenolic and ﬂavonoid content of the medicinal plants
Since the extracts showed variations in their antiviral activity,
they were checked for their total phenolic and ﬂavonoid con-
tent. The total phenolic content and ﬂavonoid content of the
selected medicinal plants are presented in Fig. 3. The phenolic
content was high with MP15 (84.55 mg/g), MP16 (82.64 mg/g)
followed by MP3 (63.59 mg/g) and MP4 (62.39 mg/g). In the
meantime MP7 (28.69 mg/g) followed by MP1 (30.53 mg/g)
registered lowest phenolic content (Fig. 3B). In the case of
ﬂavonoids it was observed that the content was high with
MP9 (47.38 mg/g) followed by MP4 (46.33 mg/g). MP7
(11.88 mg/g) followed by MP2 (13.43 mg/g) registered least ﬂa-
vonoid content among the medicinal plants analysed (Fig. 3A).
3.4. Metabolite analysis by HPLC
In addition to these results, the individual phenolic and ﬂavo-
noid content of the selected medicinal plants are proﬁled using
HPLC against the available individual standards for identiﬁca-
tion and are presented in Fig. 4. A total of 10 metabolites were
identiﬁed from the samples and all these 10 metabolites were
not identiﬁed in all the plants. Result revealed that the ﬂavo-
noid and phenolic acid content varied between the plants.
The gallic acid and the naringin content were high with MP3
whereas caffeic acid, p-Coumaric acid and hesperidin content
were high with MP4. o-Coumaric acid and vatic acid content
were high with MP16. In the case of ferulic acid, rutin and
quercetin were high with MP8.Based on the result it was clear that the medicinal plant con-
tains variations in their metabolic content and anti-viral activ-
ity. When comparing the phenolic and ﬂavonoid content the
plants possessing high ﬂavonoid content did not show high
anti-viral activity against H1N1 but the level of ﬂavonoid rang-
ing from 16.77 to 23.78 (mg/g) registered good antiviral activ-
ity. The medicinal plants such as MP3, MP4, MP15 and
MP16 showed high total phenolic content and high cytotoxicity
to the MDCK cells. In the case of MP9 even though the pheno-
lic content was higher than MP11 its activity against virus was
not good. According to Mennen et al. (2005) the high phenolic
content was responsible for the cytotoxicity to the normal cells
and the similar result was observed in this study. Because of
high polyphenol induced pro-oxidation in the cells the concen-
tration is important for ﬁnding the suitable medicinal plant
source for anti-viral activity (Sakihama et al., 2002). Compar-
ing the IC50 and TI values of MP11, it can be a potential source
for new therapeutic developments even though its CC50 value
was low when compared to the control drug. A. paniculata
(MP10) was reported for respiratory problems and H1N1 ﬂu
preventive management in a slowdown of the cold infection
time (Arora et al., 2010; Coon and Ernst, 2004). But in our
study, it resulted in poor activity against H1N1 and this may
be due to some toxic compounds which highly react with the
cells and weaken them and hence their attachment to the walls
was disturbed and because of that the IC50 values are not calcu-
latable. When comparing with the control antiviral drug Osel-
tamivir, the plant MP11 showed activity with 2.25 lg/ml (IC50)
and hence this plant can be used for some active metabolite
identiﬁcation and new pharmaceutical preparations.
In conclusion, this study reveals various ethnic medicinal
plant activities against H1N1 along with metabolic variations.
W. tinctoria (2.25 lg/ml) is found to be more active against
Figure 4 HPLC based metabolic proﬁling of the selected medicinal plants of South India. tR-retention time; log10 values of the peak
area were plotted in x-axis; MP-medicinal plants.
196 K.M. Maria John et al.H1N1 than the control drug Oseltamivir (6.44 lg/ml). Based
on the IC50, CC50 and TI of the ethnic medicinal plants ofSouth India, it can be a rich source for the development of
antidotes against H1N1.
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